Jianjing Cao

Title: Jianjing Cao: Innovator in Monoamine Transporter Inhibitors

Introduction

Jianjing Cao is a notable inventor based in Ellicott City, MD (US). He has made significant contributions to the field of pharmacology, particularly in the development of inhibitors for monoamine transporters. With a total of 5 patents, his work has implications for treating various neuropsychiatric disorders.

Latest Patents

Cao's latest patents include "Potent and selective inhibitors of monoamine transporters; method of making; and use thereof." This patent discloses bisarylmethylthioacetamides and bisarylmethylthioethylamines that serve as effective inhibitors of dopamine (DA), serotonin (5-HT), and norepinephrine (NE) reuptake. The compounds are designed to target their respective transporters, DAT, SERT, and NET. Additionally, the patent outlines methods for promoting wakefulness, enhancing cognitive function, and treating disorders such as substance use disorders, attention deficit (hyperactivity) disorder, depressive disorders, and bipolar disorder.

Career Highlights

Cao has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of North Texas. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.

Collaborations

Cao has collaborated with notable colleagues, including Amy Hauck Newman and Oluyomi M Okunola-Bakare. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.

Conclusion

Jianjing Cao's work in developing potent inhibitors of monoamine transporters showcases his dedication to advancing medical science. His contributions have the potential to improve treatment options for various neuropsychiatric disorders, making him a significant figure in the field of pharmacology.